Cardinal Health Tops EPS Forecast by $0.05, Revenue Falls Short
We see Cardinal Health as a key player in the stock market. The company just shared its Q2 results for calendar year 2025. Revenue hit $60.16 billion, flat from last year and short of the $60.75 billion analysts expected by 1%.
Adjusted earnings per share came in at $2.08. This beat the forecast of $2.03 by $0.05, or 2.4%. Adjusted EBITDA reached $743 million, below estimates by 10.7%.
For fiscal year 2026, Cardinal Health guides adjusted EPS to $9.40 at the midpoint. The range is $9.30 to $9.50. This tops analyst views by 1.6%.
What This Means for Cardinal Health in the Stock Market
Cardinal Health stands out in the stock market. Founded in 1979, it focuses on health care services. Its stock trades on NYSE under CAH.
The stock closed at $157.66. It rose 53.69% over the past year. Investors watch such growth closely.
Analysts predict 11.8% revenue growth in the next 12 months. This beats the 4.2% annual growth over two years. It also tops the 7.8% over five years.
Breaking Down the Earnings Report
We look at the details of Cardinal Health‘s earnings. Revenue stayed flat year over year. It missed estimates by a small margin.
Adjusted EPS showed strength. The beat of $0.05 drew attention. It signals solid operations.
Adjusted EBITDA fell short. Yet, the EPS win balanced this out. Stock market reactions often hinge on such metrics.
Guidance and Future Outlook for Cardinal Health
Cardinal Health offers clear guidance. For FY 2026, EPS midpoint is $9.40. This range gives room for performance.
The guidance beats consensus. It boosts confidence in the stock market. Growth prospects look bright.
Revenue growth forecasts improve. From past rates, the jump to 11.8% stands out. We see potential here.
Financial Health Rating of Cardinal Health
InvestingPro rates Cardinal Health as great performance. This score reflects strong finances. It aids stock market positioning.
The company shows resilience. Despite revenue misses, profits shine. Such health draws investors.
We note the stock’s rise. A 53.69% gain speaks volumes. It outpaces many peers.
Key Metrics at a Glance
We present key figures in a table for clarity.
This table sums up the essentials. It helps readers grasp the data fast.
How Cardinal Health Stacks Up in the Stock Market
Cardinal Health competes in health care distribution. Its results affect the stock market. We compare it to industry trends.
Many firms face revenue pressure. Yet, Cardinal Health excels in EPS. This sets it apart.
The stock’s climb shows trust. Investors value steady guidance. We see this as a positive sign.
Challenges Ahead
Revenue misses raise questions. Flat growth needs attention. Cardinal Health must address this.
EBITDA shortfalls add caution. Operations may need tweaks. The stock market watches closely.
Opportunities for Growth
Guidance points to upside. Higher revenue growth excites. Cardinal Health builds on strengths.
The health rating supports this. Great performance means solid footing. It aids future moves.
Historical Context
Cardinal Health started in 1979. It grew into a major name. Revenue trends show steady progress.
Over five years, 7.8% growth annualized. Last two years saw 4.2%. Now, forecasts jump to 11.8%.
This shift marks improvement. The stock market rewards such turns. We track these changes.
Final Thoughts
We wrap up with key points. Cardinal Health topped EPS forecasts. Revenue fell short, but guidance inspires.
The stock shows strong gains. Financial health rates high. This positions it well in the stock market.
Disclaimer:
This is for informational purposes only and does not constitute financial advice. Always do your research.